Search Within

PARKINSON’S DISEASE (PD)
Natural Products Combating Neurodegeneration: Parkinson’s Disease

Journal: Current Drug Metabolism
Volume: 18,Issue: 1
Page: 50-61
Authors: Md. Solayman, Md. Asiful Islam, Fahmida Alam, Md. Ibrahim Khalil, Mohammad Amjad Kamal and Siew Hua Gan

Revisiting the Medical Management of Parkinson’s Disease: Levodopa versus Dopamine Agonist

Journal: Current Neuropharmacology
Volume: 14,Issue: 4
Page: 356-363
Authors: Jinglin Zhang and Louis Chew-Seng Tan

Current Pharmaceutical Treatments and Alternative Therapies of Parkinson’s Disease

Journal: Current Neuropharmacology
Volume: 14,Issue: 4
Page: 339-355
Authors: Jie Dong, Yanhua Cui, Song Li and Weidong Le

Aminochrome as New Preclinical Model to Find New Pharmacological Treatment that Stop the Development of Parkinson’s Disease

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 4
Page: 346-359
Authors: Juan Segura-Aguilar, Patricia Muñoz and Irmgard Paris

An Overview on the Role of α -Synuclein in Experimental Models of Parkinson’s Disease from Pathogenesis to Therapeutics

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15,Issue: 10
Page: 1240-1252
Authors: Hayate Javed, Mohammad Amjad Kamal and Shreesh Ojha

Aporphines and Parkinson’s Disease: Medical Tools for the Future

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 17
Page: 1906-1909
Authors: Seyed Fazel Nabavi, Eugenio Uriarte, Luca Rastrelli, Brenda Modak and Eduardo Sobarzo-Sánchez

Parkinson’s Disease: Recent Updates in the Identification of Human Dopa Decarboxylase Inhibitors

Journal: Current Drug Metabolism
Volume: 17,Issue: 5
Page: 513-518
Authors: Riccardo Montioli, Carla B. Voltattorni and Mariarita Bertoldi

Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 2
Page: 238-246
Authors: Amir Sarrafchi, Mahmoud Bahmani, Hedayatollah Shirzad and Mahmoud Rafieian-Kopaei

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 10
Page: 1305-1311
Authors: Juan Camilo Jurado-Coronel, Marco Avila-Rodriguez, Francisco Capani, Janneth Gonzalez, Valentina Echeverria Moran and George E. Barreto

Nose to Brain Delivery of Nanoformulations for Neurotherapeutics in Parkinson’s Disease: Defining the Preclinical, Clinical and Toxicity Issues

Journal: Current Drug Delivery
Volume: 13,Issue: 8
Page: 1205-1221
Authors: Kamla Pathak and Nida Akhtar

LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?

Journal: Current Neuropharmacology
Volume: 14,Issue: 3
Page: 214-225
Authors: Jean-Marc Taymans and Elisa Greggio

Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson’s Disease

Journal: Current Neuropharmacology
Volume: 14,Issue: 3
Page: 250-259
Authors: Alice Nardin, Emilie Schrepfer and Elena Ziviani

Parkinson's Disease, Diabetes and Cognitive Impairment

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 10,Issue: 1
Page: 11-21
Authors: Mohammad R. Ashraghi, Gennaro Pagano, Sotirios Polychronis, Flavia Niccolini and Marios Politis

Development of Monoamine Oxidase B Inhibitors with Antiparkinson Activity

Journal: Current Physical Chemistry
Volume: 6,Issue: 1
Page: 40-52
Authors: Lucilene R. de Souza, Rafael de Matos Picanço, Abraão A. Pinheiro, Karina R. da Silva, Carlton A. Taft, Carlos H. T. de Paula da Silva, Cleydson B. R. dos Santos and Lorane I. da Silva Hage-Melim

Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View

Journal: Current Neuropharmacology
Volume: 14,Issue: 3
Page: 260-271
Authors: Roberta Filograna, Mariano Beltramini, Luigi Bubacco and Marco Bisaglia

Previous     Next

Go To   Results 1 - 15 of 3439